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Abstract: In Western populations, the caffeine intake of young adults has received significant attention
in the research literature; our knowledge in other societies remained limited. The objective of this
research is to quantify the amount of ingested caffeine and how this is related to measures of physical
and mental health in a Bahraini population. A semi-quantitative food frequency questionnaire was
used to estimate caffeine intake from coffee, tea, cocoa, soft drinks, energy drinks, chocolates, and
over-the-counter medications. Associations between caffeine intake, demographic variables and
25 symptoms measured using the Hopkins Symptoms Checklist-25 were examined. A convenience
sample of university students in Bahrain (n = 727) was surveyed. Caffeine, in any form, was consumed
by 98% of students. Mean daily caffeine consumption was 268 mg/day, with males consuming more
than females. Coffee was the main source of caffeine intake, followed by black tea and energy
drinks. Participants consuming 400 mg/day or more showed a statistically and significantly twice
as high risk for five symptoms, these were: headaches, spells of terror or panic, feeling trapped or
caught, worrying too much about things, and having feelings of worthlessness. The prevalence of
caffeine intake among university students in Bahrain is high. The overall mean intake of caffeine
from all sources by university students was within levels considered to be acceptable by many
dietary recommendations. High caffeine intake was associated with an anxiogenic effect in the
surveyed students.
Keywords: caffeine; coffee; energy drink; tea; university students
1. Introduction
Caffeine is the most widely consumed central nervous system stimulant in the world [1] and one
of the most extensively studied elements in the human diet [1,2]. Caffeine can be ingested in foods
made from natural sources such as coffee, tea, and chocolates [3]. However, synthetic caffeine is often
added to food products and beverages to enhance their stimulant properties [3]. Several studies have
quantified the ingested caffeine by adults [3–6]. Estimates suggest that adults consume a daily average
of 180–190 mg caffeine [3–6], which is about two to three cups of coffee. Coffee appeared to be the
major source of caffeine, followed by soft drinks and tea [3].
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The popularity of caffeine stems from the various subjective benefits that individuals associate
with its intake; these include increased attentiveness and alertness, increased work performance,
enhanced vigilance, elevated mood and delayed onset of sleep [7]. Different populations use caffeine
for various reasons; for example, doctors and surgeons use caffeine to reduce fatigue and increase
alertness [8], athletes use caffeine to enhance their physical performance [9], while young adults use
caffeine to get more energy, or for the taste, or as part of social gathering or for image enhancement [10].
Coffee intake varies worldwide: Nordic countries have the largest intake: people in Finland,
Norway, Iceland, Denmark, and Sweden consume an average of 12 kg, 9.9 kg, 9.0 kg, 8.7 kg and 8.2 kg
of coffee per capita per year, respectively [11]. Our knowledge of other societies remains limited.
Several studies showed that consuming a moderate amount of caffeine has a protective effect
against cancer [12], diabetes mellitus type 2 [13], inflammatory diseases and pain [14], Parkinson’s and
related neurodegenerative diseases [15], cardiovascular disease [16], and stroke [17]. Light to moderate
caffeine intake has also been found to be associated with reduced risk of death [18] from all causes,
including suicide [19].
However, intake of caffeine in high doses may lead to adverse effects on health [20]. A recent
systematic review identified several unwanted symptoms associated with a high daily intake of caffeine;
these include palpitations, headache, tremors, anxiety, agitation, restlessness, and sleep problems [21].
Research also shows that university students might be at a particularly high risk of adverse
effects due to their high intake of caffeine [4]. For example, high caffeine use by university students
is associated with sleep problems, particularly poor sleep duration and quality as well as excessive
daytime sleepiness [22–24]. University students who are trying to control or lose weight are more
likely to consume higher amounts of caffeine [25]. Binge alcohol drinking is also associated with the
intake of energy drinks and other caffeinated beverages by university students [26].
Taking all of the above information collectively, it becomes clear that more research is necessary to
study the overall intake of caffeine and its potential cumulative effects on physiology and behavior
among populations vulnerable to its negative effects. Given the absence of previous research that
focuses on the quantification of caffeine intake, its sources and its impact on health among Bahraini
university students; the topic warrants further attention. The Bahraini student population consists
mainly of Arab and Muslim individuals, which makes them different from other populations.
The current study aimed to assess caffeine intake from a wide variety of caffeinated products,
including beverages, chocolates, gums and over-the-counter (OTC) medications among a convenience
sample of university students in Bahrain. The presence and severity of 25 physical and mental
symptoms were assessed using the Hopkins Symptom Checklist-25 (HSCL-25). Associations between
caffeine intake and symptomatology and selected socio-demographic variables such as sex, race,
income, and anthropometric variables were examined.
We hypothesized that high caffeine intake would be associated with the cluster of symptoms that
define anxiety, such as headache, palpitation, tremors, panic attacks and restlessness.
2. Materials and Methods
The guidelines of the Strengthening the Reporting of Observational Studies in Epidemiology
statement were adopted in planning, implementing, and reporting the study [27].
2.1. Study Design
The cross-sectional research design was used to assess caffeine intake from a wide variety of
caffeinated products, including beverages, chocolates, gums and OTC medications among a convenience
sample of university students in Bahrain.
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2.2. Setting and Participants
The study was conducted using an online survey in December 2019. A convenience sample of
university students was recruited through an online information weblink circulated using the social
network platform WhatsApp®. A link to the questionnaire in an Arabic language Google Forms format
was initially posted on several WhatsApp® chat groups of students in six universities: Arabian Gulf
University, University of Bahrain, Applied Science University of Bahrain, Ahlia University, Bahrain
Polytechnic, and AMA International University of Bahrain. When the students clicked on the link,
they were taken to the electronic Google Form. Google Form saves each completely filled questionnaire
in the investigator’s Google drive. Upon completing the questionnaire, the students were asked to
forward the survey link to their WhatsApp® study groups/siblings/partners. All the completed forms
were available to view on the drive, which was password-protected and could be downloaded when
needed for analysis. Only students who were not enrolled in any program at a university located in
Bahrain or those who were not willing to participate and providing informed consent were excluded.
Participants were able to answer the questions within their own time frame, enabling them to have
privacy or choice of space.
Using a margin of error of 5% (alpha error), a confidence level of 95% and a response rate of 50%
from a given population of approximately 40,000 students in Bahrain, we estimated that 380 would be
the minimum viable sample size for sufficiently powered analyses. The endpoint used to power the
analysis was assuming that 15% or more of the students would consume high amounts of caffeine
(≥400 mg/day).
2.3. Tools and Techniques
An Arabic language, self-administered questionnaire was used to collect the data.
The questionnaire consisted of structured, closed-ended questions. There were no open-ended or
continuing questions, making the questionnaire simple and quick to answer; the investigator estimated
that it would take each participant around 7 to 10 min to complete their form based on a pilot test
activity. The questionnaire was divided into three domains; socio-demographics and anthropometrics,
daily caffeine intake, and the HSCL-25 [28].
2.4. Variables
As described above, the survey collected data on a number of socio-demographic and
anthropometrics. These included: sex, marital status, income, race, university major, tuition
payment plan, academic year, general health, age and self-reported anthropometrics (weight and
height). Self- reported measurement has been found to be both valid and reliable when compared
to measurements taken directly by researchers [29–31]. Body mass index (BMI) was calculated using
reported weight and height, dividing the weight in kilograms on the squared height in meters.
Individuals with BMI < 18.5 were classified as underweight, individuals with BMI ≥ 18.5 and <24.9
were classified as being in the normal weight range, while a BMI ≥ 25.0 and <29.9 was considered as
overweight and individuals with BMI ≥ 30.0 were classified as obese.
The self-report survey instrument included detailed semi quantitative food frequency questionnaire
questions on types of caffeine-containing products consumed, and the serving size and the frequency
of intake. A diverse variety of 38 caffeine-containing items were included as a response option in
the caffeine intake section. The caffeine-containing items were: coffee, decaf coffee, concentrated
coffee including Arabic coffee and espresso, black tea, green tea, cocoa, energy drinks, soft drinks
(sodas/fizzy drinks), chocolates and gums, and finally OTC caffeine-containing analgesics. Based on
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the information reported on product type and serving size, the daily caffeine intake was calculated
using data on the amount of caffeine in each specific product. Sources of caffeine content in specific
products included: United States Department of Agriculture Nutrient Database release 28 product
labels, product websites, and other reliable online sources of caffeine content.
The Arabic validated HSCL-25 is well-known and widely used to screen for psychological distress,
anxiety, and depression [28]. It consists of 25 symptoms answered on a Likert-like four categories of
response (“Not at all”, “A little bit”, “Quite a bit”, “Extremely”, rated 1 to 4, respectively). Three scores
are calculated from the HSCL-25: the total score is the average of all 25 items, while the depression
score is the average of 15 items, and the anxiety score is the average of 10 items. It has been consistently
shown among several populations that the total score is highly correlated with the severe emotional
distress of unspecified diagnosis, the depression score is correlated with major depression and the
anxiety score is correlated with anxiety, as defined by the Diagnostic and Statistical Manual of the
American Psychiatric Association, 4th Edition. The 25 individual symptoms of the HSCL-25 and the
corresponding three scores of psychological distress, anxiety and depression were classified to binary
for subsequent analyses. For the individual 25 symptoms, a response of “Not at all” was considered
normal, while a response of “A little bit” or “Quite a bit” or “Extremely” were considered symptomatic.
For psychological distress, anxiety and depression, a cut-off of 1.75 was used to differentiate normal
from abnormal or pathological scores.
2.5. Ethical Consideration
The Research Ethics Committee (REC) of the Arabian Gulf University approved the research
(E15-PI-12/19), and data collection was started following the approval. Electronic informed consent was
sought and obtained from the participants. Participation was voluntary; no monetary or non-monetary
incentives were given and the participant was permitted to withdraw at any time.
2.6. Statistical Analysis
The data were analyzed using STATA 16 (Version 16, 2019, College Station, TX: StataCorp LLC) [32].
Descriptive statistics were used to summarize participants’ socio-demographic and anthropometric
characteristics; the arithmetic mean and standard deviation (SD) were reported for continuous
variables, and count and percentage were reported for categorical variables. To compare the two
groups, the independent sample t-test was used for continuous variables and Chi-square was used for
categorical variables.
The U.S. Food and Drug Administration has cited 400 milligrams per day as a safe dose of
caffeine [33]. Thus, to examine the association between high caffeine intake (≥400 mg/day) and the
symptoms of the HSCL-25, logistic regression was performed, and odds ratio (OR) and 95% confidence
intervals (95% CI) were computed, and significance was considered at p-value < 0.05. In the regression
model, the independent variable was high caffeine intake (≥400 mg/day) or normal caffeine intake
(<400 mg/day). The dependent variable was absence of symptoms (not at all) or the presence of
symptoms (a little bit, quite a bit, extremely) for the individual scores pf the symptoms of the HSCL-25;
or a cut off of 1.75 for psychological distress, anxiety or depression scores.
3. Results
Descriptive socio-demographic and anthropometric characteristics of the study participants are
presented in Table 1. The majority of the participants were female (approx. 63%), single (approx.
92%), Arab race (approx. 97%), with a monthly income of ≥$500 (approx. 68%). The mean age was
20.72 ± 1.9 and the mean BMI of 24.0 ± 5.46.
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Table 1. Descriptive sociodemographic and anthropometric characteristics of the study participants.
Variable Participants, n = 727 n(%)/Arithmetic Mean ± SD
Sex
Male 269 (37%)
Female 458 (63%)
Marital status
Not married 669 (92.02%)
Married 58 (7.98%)
Income/month
≥$500 495 (68.09%)
$500–$1000 101 (13.89%)
+$1000 131 (18.02%)
Race
Arab 705 (96.97%)
Non-Arab 22 (3.03%)
University major
Medical and Health Sciences 310 (42.64%)
Education 22 (3.03%)
Engineering 78 (10.73%)
Law 69 (9.49%)
Business Administration 116 (15.96%)
Computer Sciences 25 (3.44%)
Other specialties 107 (14.72%)
Tuition payment plan
Personal 280 (38.51%)
Scholarship 358 (49.245)
Other Funds 89 (12.24%)
Academic year
First 242 (33.29%)
Second 156 (21.46%)
Third 101 (13.89%)
Fourth 104 (14.31%)
Fifth 49 (6.74%)
Sixth 75 (10.32%)
Age (year) 20.72 ± 1.9
Height (cm) 163.91 ± 9.22
Weight (kg) 64.73 ± 16.53
Body mass index, BMI (kg/m2) 24.0 ± 5.46
The daily intake of caffeine of the study participants is presented in Table 2. The vast majority
(approx. 98%) of the participants reported regular daily intake caffeine products. Approximately
76% of the participants consumed at least one cup of regular coffee per day, 20% consumed at least
one cup of decaffeinated coffee per day, 55% consumed at least one shot of concentrated coffee per
day, 72% consumed at least one cup of black tea per day, 20% consumed at least one cup of green tea
per day, 20% consumed at least one cup of cocoa per day, 22% consumed at least one can of energy
drink per day, 55% consumed at least one can of soft drink per day, 70% consumed at least one bar of
chocolate per day, and 34% consumed at least one tablet of OTC pain remedies containing caffeine
per day.
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Table 2. Daily caffeine intake by the study participants.
Part 1: Daily Intake Frequency of Caffeine by Source
Variable * Participants, n = 727
Intake frequency of regular coffee
None 174 (23.93%)
1–2 Units 439 (60.39%)
3–4 Units 94 (12.93%)
≥5 Units 20 (2.76%)
Intake frequency of decaf coffee
None 589 (81.02%)
1–2 Units 107 (14.72%)
3–4 Units 21 (2.89%)
≥5 Units 10 (1.38%)
Intake frequency of concentrated coffee
None 326 (44.84%)
1–2 Units 275 (37.83%)
3–4 Units 89 (12.24%)
≥5 Units 37 (5.09%)
Intake frequency of black tea
None 205 (28.2%)
1–2 Units 371 (51.03%)
3–4 Units 95 (13.07%)
≥5 Units 56 (7.70%)
Intake frequency of green tea
None 597 (82.12%)
1–2 Units 109 (14.99%)
3–4 Units 16 (2.20%)
≥5 Units 5 (0.69%)
Intake frequency of cocoa
None 583 (80.19%)
1–2 Units 132 (18.16%)
3–4 Units 6 (0.83%)
≥5 Units 6 (0.83%)
Intake frequency of energy drinks
None 562 (77.3%)
1–2 Units 144 (19.81%)
3–4 Units 11 (1.51%)
≥5 Units 10 (1.38%)
Intake frequency of soft drinks
None 326 (44.84%)
1–2 Units 346 (47.59%)
3–4 Units 42 (5.78%)
≥5 Units 13 (1.79%)
Intake frequency of chocolate and gums
None 212 (29.16%)
1–2 Units 431 (59.28%)
3–4 Units 65 (8.94%)
≥5 Units 19 (2.34%)
Intake frequency of over the counter medications
(tablet)
None 482 (66.3%)
1–2 Units 172 (23.66%)
3–4 Units 48 (6.60%)
≥5 Units 11 (3.44%)
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Table 2. Cont.
Part 2: Mean Daily Intake of Caffeine by Source
Regular coffee mg/day 133.29 ± 130.93
Decaf coffee mg/day 1.15 ± 3.21
Concentrated coffee mg/day 61.14 ± 85.24
Black tea mg/day 80.88 ± 94.03
Green tea mg/day 10.69 ± 32.56
Cocoa mg/day 4.5 ± 13.94
Energy drinks mg/day 56.53 ± 159.1
Soft drinks mg/day 27.24 ± 38.16
Chocolate and gums mg/day 18.24 ± 21.85
Over the counter medications mg/day 7.66 ± 15.61
All sources mg/day 268.03 ± 319.83
Part 3: Prevalence of High Intake of Caffeine
Caffeine ≥400 mg/day 130 (17.88%)
Caffeine ≥500 mg/day 82 (11.28%)
Caffeine ≥600 mg/day 51 (7.02%)
Caffeine ≥700 mg/day 32 (4.40%)
Caffeine ≥800 mg/day 20 (2.75%)
Caffeine ≥900 mg/day 17 (2.34%)
Caffeine ≥1000 mg/day 15 (2.06%)
Caffeine ≥2000 mg/day 4 (0.55%)
* Units are Standard Cup = 240 milliliters (8 US fluid ounces), Shot cup = 30 milliliters (1 US fluid ounces), Soft drink
can =330 milliliters (11 US fluid ounces), Energy drink can =250 milliliters (8 US fluid ounces), Bar = 57 g (2 ounces).
The mean daily caffeine intake was estimated to be 268 mg/day from all sources. The main sources
of caffeine: regular coffee, black tea, concentrated coffee, and energy drinks with 133 mg/day, 81 mg/day,
61 mg/day, and 56 mg/day were obtained from these products per person; respectively.
Mean caffeine intake from all sources was higher for males (306 mg/day) than for females
(246 mg/day) (p = 0.01). There were no statistically significant differences between males and females in
the amount of caffeine consumed from regular coffee, decaf coffee, concentrated coffee, green tea, cocoa,
energy drinks, and chocolate and gums. Males consumed more caffeine from black tea (p < 0.001) and
soft drinks (p < 0.001) compared to females. Females consumed more caffeine from OTC medications
(p < 0.001) compared to males.
About 18% of the study participants consumed 400 mg/day or more according to Table 2. Only four
participants (0.5%) consumed 2000 mg/day or more.
Table 3 provides the distribution of the symptoms listed in the HSCL-25 of the study participants.
The most prevalent symptoms were “Nervousness or shakiness inside”, “Feeling no interest in
things”, “Blaming yourself for things”, “Headaches”, “Feeling everything is an effort”, “Feeling blue”,
“Feeling restless, can’t sit still”, “Difficulty falling asleep, staying asleep”, “Feeling low in energy–slowed
down”, and “Feeling fearful”. Scores of the HSCL-25 show that approx. 47% experienced anxiety
disorders and approximately 9% experienced depressive disorders. The global score indicates that just
more than half (55%) experienced psychological distress.
Table 4 provides the strength of association between consuming a high amount of caffeine
(>400 mg/day) and the symptoms of the HSCL-25. Participants consuming 400 mg/day or more
showed statistically significantly difference for five symptoms, these were: headaches (OR = 1.84,
p = 0.02, 95% CI = 1.11–3.03), spells of terror or panic (OR = 1.82, p = 0.001, 95% CI = 1.21–2.75),
feeling trapped or caught (OR = 2.05, p = 0.001, 95% CI = 1.32–3.19), worrying too much about
things (OR = 1.72, p = 0.01, 95% CI = 1.16–2.53), feelings of worthlessness (OR = 1.57, p = 0.03,
95% CI = 1.06–1.06), anxiety score (OR = 1.80, p = 0.001, 95% CI = 1.22–2.64), and psychological distress
score (OR = 1.79, p = 0.001, 95% CI = 1.20–2.66).
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Table 3. Distribution of Hopkins Symptom Checklist—25 items (HSCL-25) of the study participants.
Symptom of HSCL-25 Healthy Symptomatic *
Not at all (1) A little bit (2) Quite a bit (3) Extremely (4)
Suddenly scared for no reason 322 (44.29%) 319 (43.88%) 63 (8.67%) 23 (3.16%)
Feeling fearful 251 (34.53%) 385 (52.96%) 69 (9.49%) 22 (3.03%)
Faintness, dizziness, or weakness 393 (54.06%) 251 (34.53%) 70 (9.63 %) 13 (1.79%)
Nervousness or shakiness inside 131 (18.02%) 316 (43.47%) 202 (27.79%) 78 (10.73%)
Heart pounding or racing 277 (38.1%) 312 (42.92%) 90 (12.38%) 48 (6.60%)
Trembling (Tremors) 420 (57.77%) 221 (30.40%) 67 (9.22%) 19 (2.61%)
Feeling tense or keyed up 348 (47.87 %) 239 (32.87%) 92 (12.65 %) 48 (6.60 %)
Headaches 177 (24.35%) 366 (50.34 %) 129 (17.74%) 55 (7.57%)
Spells of terror or panic 552 (75.93%) 122 (16.78%) 34 (4.68%) 19 (2.61%)
Feeling restless, can’t sit still 243 (33.43%) 308 (42.37%) 115 (15.82%) 61 (8.39%)
Feeling low in energy—slowed down 245 (33.7 %) 297 (40.85%) 120 (16.51%) 65 (8.94%)
Blaming yourself for things 176 (24.21%) 252 (34.66%) 178 (24.48%) 121 (16.64%)
Crying easily 266 (36.59%) 233 (32.05%) 122 (16.78%) 106 (14.58%)
Loss of sexual interest or pleasure 480 (66.02%) 139 (19.12%) 57 (7.84%) 51 (7.02%)
Poor appetite 310 (42.64%) 313 (43.05%) 78 (10.73%) 26 (3.58%)
Difficulty falling asleep, staying asleep 244 (33.56%) 256 (35.21%) 143 (19.67%) 84 (11.55%)
Feeling hopeless about the future 291 (40.03%) 246 (33.84%) 108 (14.86%) 82 (11.28%)
Feeling blue 239 (32.87%) 304 (41.82%) 105 (14.44%) 79 (10.87%)
Feeling lonely 284 (39.06%) 235 (32.32%) 111 (15.27%) 97 (13.34%)
Feeling trapped or caught 597 (82.12%) 70 (9.63%) 24 (3.30%) 36 (4.95%)
Worrying too much about things 359 (49.38%) 257 (35.35%) 74 (10.18%) 37 (5.09%)
Feeling no interest in things 135 (18.57%) 250 (34.39%) 189 (26%) 153 (21.05%)
Thoughts of ending your life 258 (35.49%) 288 (39.61%) 113 (15.54%) 68 (9.35%)
Feeling everything is an effort 224 (30.81%) 295 (40.58%) 125 (17.19%) 83 (11.42 %)
Feelings of worthlessness 322 (44.29%) 224 (30.81%) 81 (11.14%) 100 (13.76%)
Scoring of (HSCL-25)
Prevalence of anxiety ** 344 (47.32%)
Prevalence of depression *** 65 (8.94%)
Prevalence of Psychological Distress **** 404 (55.57%)
* Symptoms distribution; A little bit = mild symptoms, Quite a bit = moderate symptoms, Extremely = severe symptoms;
** Defined by items 1–10, (
∑
1–10/10) and a score ≥1.75 is considered abnormal; *** Defined by items 11–25, (∑11–25/15) and
a score ≥1.75 is considered abnormal; **** Defined by items 1–25, (∑1–25/25) and a score ≥1.75 is considered abnormal.
Table 4. The association between high caffeine intake (>400 mg/day) and symptoms of the
study participants.
Symptom OR ** p-Value 95% Confidence Interval
Suddenly scared for no reason 1.15 0.49 0.78 1.68
Feeling fearful 1.13 0.56 0.75 1.69
Faintness, dizziness, or weakness 0.90 0.60 0.62 1.32
Nervousness or shakiness inside 1.57 0.11 0.91 2.72
Heart pounding or racing 0.91 0.62 0.62 1.34
Trembling (Tremors) 1.17 0.42 0.80 1.71
Feeling tense or keyed up 1.17 0.41 0.80 1.72
Headaches 1.84 0.02 * 1.11 3.03
Spells of terror or panic 1.82 0.001 * 1.21 2.75
Feeling restless, can’t sit still 1.27 0.26 0.84 1.92
Feeling low in energy—slowed down 0.95 0.81 0.64 1.42
Blaming yourself for things 0.88 0.57 0.57 1.36
Crying easily 0.72 0.09 0.49 1.05
Loss of sexual interest or pleasure 1.17 0.43 0.79 1.74
Poor appetite 0.94 0.76 0.64 1.38
Difficulty falling asleep, staying asleep 1.03 0.90 0.69 1.54
Feeling hopeless about the future 1.27 0.23 0.86 1.89
Feeling blue 0.95 0.80 0.63 1.42
Feeling lonely 1.21 0.34 0.82 1.80
Feeling trapped or caught 2.05 0.001 * 1.32 3.19
Worrying too much about things 1.72 0.01 * 1.16 2.53
Feeling no interest in things 0.75 0.23 0.47 1.19
Thoughts of ending your life 1.19 0.40 0.79 1.78
Feeling everything is an effort 1.00 0.99 0.66 1.51
Feelings of worthlessness 1.57 0.03 * 1.06 2.33
Anxiety score 1.80 0.001 * 1.22 2.64
Depression score 1.29 0.42 0.69 2.41
Psychological distress score 1.79 0.001 * 1.20 2.66
* Significant at 0.05; ** Odds ratio, adjusted for age, sex and BMI.
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4. Discussion
The present study aimed to quantify caffeine intake by university students using data from a
convenience sample of over 700 students from different universities in Bahrain. The study is based on a
detailed survey that examined the frequency and quantity of intake of an extensive range of commonly
available caffeinated products. The study also used the HSCL-25 to examine the association between
high caffeine intake and mental health.
About 98% of students reported regular daily intake of caffeine, with the majority consuming
coffee, tea, and soft drinks. The total mean caffeine intake was 268 mg/day. Our results are slightly
higher than the published estimates of the intake of caffeine by U.S. and Dutch university students,
who consume an average of 159 mg/day and 144 mg/day, respectively [6,34]. One possible explanation
for the higher intake of caffeine in our study population is the fact that caffeinated beverages are the
most commonly available drink products for university students and young adults in Arab and Muslim
countries. This proposition is supported by the findings of caffeine intake among university students
in a neighboring country, the United Arab Emirates (UAE), where caffeine intake was estimated to
be approximately 250 mg/day [35]. In the Arab region, caffeinated beverages, especially tea and
coffee, are an essential part of hospitability in every social event, thus, their intake is influenced by
social norms.
Similar to U.S., Dutch and UAE students, Bahraini students surveyed consumed most of their
caffeine from coffee (133 mg/day) and tea (81 mg/day). The daily intake of caffeine from energy drinks
in Bahraini students was 56 mg/day, which is similar to results from the U.S. [6] Consistent with
previous research, our study suggests that caffeinated beverages make the largest contribution to the
total caffeine intake per day amongst all the examined sources of caffeine [3,34].
The overall mean intake of caffeine from all dietary and non-dietary sources by university students
was within levels considered to be acceptable by many dietary recommendations. About one-fifth
of the students consumed more caffeine (over 400 mg/day) than is advised [7,36]. Levels of unsafe
or maximum caffeine intake remain debatable, due to limited safety data. Our research shows that
high caffeine use is associated with the following symptomatology: headaches, spells of terror or
panic, feeling trapped or caught, worrying too much about things, anxiety and psychological distress.
The present study is the first and largest to examine the association of daily caffeine intake from
caffeine-containing products with symptoms among university students in Bahrain.
Because this is an observational study, we cannot demonstrate a causal link between caffeine intake
and present pointed out anxiety-related symptoms reported by students in this study. The pharmacology
of caffeine and related methylxanthines is complex, as they modulate a variety of biological targets.
Nevertheless, clinical and experimental investigations of caffeine pharmacology provide biological
plausibility to some of these effects, as outlined in a recent comprehensive review [37]. At physiologically
relevant concentrations, the predominant pharmacological effect is as a purinoceptor antagonist.
Caffeine acts at a number of adenosine receptors, including A1 and A2A. The A1A predominates in
the brain, and the activation of A1A has been associated with anxiolytic effects [38]. Indeed, positive
allosteric modulators of A1A have been proposed as a therapeutic strategy for anxiety [38]. Based upon
laboratory observations, it is often claimed that caffeine is a phosphodiesterase inhibitor, however,
this action is unlikely to occur, at any but the very highest concentrations in vivo, and the relevance to
anxiety is unclear [37].
A recent comprehensive systematic review of the possible adverse effects of caffeine on the
cardiovascular system, bone status, reproductive health, and development, as well as behavior,
concluded that, for adults there was no evidence that a caffeine intake of up to 400 mg/day posed any
risk of adverse effects [21].
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The strengths of this study are numerous. Caffeine intake among university students was
quantified by consideration of many possible sources, rather than only from caffeinated beverages.
We included OTC medications, chocolate and gums. The examination of the association between
caffeine intake and a list of common mental/psychological symptoms related to mental health is a
novel contribution to the literature.
There are several limitations to this study. The major limitation is that the obtained data were
self-reported and various types of biases, e.g., recall bias, are becoming a challenge. The study is based
on a self-selecting convenience sample that is unlikely to be representative of the entire university
student population in Bahrain. Because this is an observational study, rather than a randomized trial,
we can only study associations between variables; we cannot demonstrate causality. Although we
adjusted the odds ratios in our logistic regression model to account for demographic data, it is very
likely that residual confounding exists.
5. Conclusions
The majority of university students consume caffeine on a daily basis; coffee is the main source
of ingested caffeine. The mean intake was 268 mg/day, with males consuming more caffeine than
females. High caffeine intake in this population was associated with headaches, anxiety, and
psychological distress.
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